203 related articles for article (PubMed ID: 26821052)
1. Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells.
Hopkins MM; Zhang Z; Liu Z; Meier KE
J Clin Med; 2016 Jan; 5(2):. PubMed ID: 26821052
[TBL] [Abstract][Full Text] [Related]
2. Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cells.
Hopkins MM; Meier KE
Prostaglandins Leukot Essent Fatty Acids; 2017 Jul; 122():24-29. PubMed ID: 28735625
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.
Liu Z; Hopkins MM; Zhang Z; Quisenberry CB; Fix LC; Galvan BM; Meier KE
J Pharmacol Exp Ther; 2015 Feb; 352(2):380-94. PubMed ID: 25491146
[TBL] [Abstract][Full Text] [Related]
4. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.
Hopkins MM; Liu Z; Meier KE
J Pharmacol Exp Ther; 2016 Oct; 359(1):124-33. PubMed ID: 27474750
[TBL] [Abstract][Full Text] [Related]
5. Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.
Hopkins MM; Meier KE
Handb Exp Pharmacol; 2017; 236():233-251. PubMed ID: 27757756
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
Hernández M; Barrero MJ; Crespo MS; Nieto ML
J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation.
Snider AJ; Zhang Z; Xie Y; Meier KE
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C163-70. PubMed ID: 19864325
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.
Karmokar PF; Moniri NH
Biochem Pharmacol; 2022 Dec; 206():115328. PubMed ID: 36309079
[TBL] [Abstract][Full Text] [Related]
9. Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes.
Holmström TE; Mattsson CL; Wang Y; Iakovleva I; Petrovic N; Nedergaard J
Exp Cell Res; 2010 Oct; 316(16):2664-75. PubMed ID: 20576526
[TBL] [Abstract][Full Text] [Related]
10. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.
Valenzuela P; Teuber S; Manosalva C; Alarcón P; Figueroa CD; Ratto M; Burgos RA; Hidalgo MA
Vet Res Commun; 2019 Aug; 43(3):179-186. PubMed ID: 31187404
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor.
Shah BH; Baukal AJ; Shah FB; Catt KJ
Mol Endocrinol; 2005 Oct; 19(10):2535-48. PubMed ID: 15928312
[TBL] [Abstract][Full Text] [Related]
14. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
16. EGF and angiotensin II modulate lysophosphatidic acid LPA(1) receptor function and phosphorylation state.
Colín-Santana CC; Avendaño-Vázquez SE; Alcántara-Hernández R; García-Sáinz JA
Biochim Biophys Acta; 2011 Dec; 1810(12):1170-7. PubMed ID: 21914461
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Tveteraas IH; Aasrum M; Brusevold IJ; Ødegård J; Christoffersen T; Sandnes D
Tumour Biol; 2016 Feb; 37(2):2519-26. PubMed ID: 26386720
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factor.
Sui JQ; Xie KP; Xie MJ
Sheng Li Xue Bao; 2016 Feb; 68(1):27-34. PubMed ID: 26915319
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
20. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.
Goppelt-Struebe M; Fickel S; Reiser CO
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
